Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gaudin

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Nephrologie|January 1, 1996
[Twenty one years of hemodialysis in a patient with primary hyperoxaluria]T Hachache, H Meftahi, M Forêt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2000
Intrarenal schwannoma: a report of four cases including three cellular variantsI Alvarado-Cabrero, A L Folpe, J R Srigley, et al.
Rheumatology (Oxford, England)|September 15, 2000
Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritisP Gaudin, S Ijaz, P W Tuke, et al.
Journal of Neurosurgery. Spine|October 5, 2019
Incidence of intraoperative hypotension in acute traumatic spinal cord injury and associated factorsXavier P Gaudin, Jacob C Wochna, Timothy W Wolff, et al.
Annals of the Rheumatic Diseases|August 13, 2005
The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis populationH Marotte, B Pallot-Prades, L Grange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancerM J Zelefsky, K E Wallner, C C Ling, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritisC Trocmé, H Marotte, A Baillet, et al.
Annals of the Rheumatic Diseases|October 16, 2009
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registryX Mariette, F Tubach, H Bagheri, et al.
Rheumatology (Oxford, England)|October 27, 1999
Rheumatic disorders developed after hepatitis B vaccinationJ F Maillefert, J Sibilia, E Toussirot, et al.
Clinical and Experimental Rheumatology|February 18, 2014
The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational studyR Westhovens, R F van Vollenhoven, D T Boumpas, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Nephrologie|January 1, 1996
[Twenty one years of hemodialysis in a patient with primary hyperoxaluria]T Hachache, H Meftahi, M Forêt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 24, 2000
Intrarenal schwannoma: a report of four cases including three cellular variantsI Alvarado-Cabrero, A L Folpe, J R Srigley, et al.
Rheumatology (Oxford, England)|September 15, 2000
Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritisP Gaudin, S Ijaz, P W Tuke, et al.
Journal of Neurosurgery. Spine|October 5, 2019
Incidence of intraoperative hypotension in acute traumatic spinal cord injury and associated factorsXavier P Gaudin, Jacob C Wochna, Timothy W Wolff, et al.
Annals of the Rheumatic Diseases|August 13, 2005
The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis populationH Marotte, B Pallot-Prades, L Grange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancerM J Zelefsky, K E Wallner, C C Ling, et al.
Annals of the Rheumatic Diseases|July 31, 2008
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritisC Trocmé, H Marotte, A Baillet, et al.
Annals of the Rheumatic Diseases|October 16, 2009
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registryX Mariette, F Tubach, H Bagheri, et al.
Rheumatology (Oxford, England)|October 27, 1999
Rheumatic disorders developed after hepatitis B vaccinationJ F Maillefert, J Sibilia, E Toussirot, et al.
Clinical and Experimental Rheumatology|February 18, 2014
The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational studyR Westhovens, R F van Vollenhoven, D T Boumpas, et al.
Pageof 7